Peninsula biotech startup uncloaks with $94M from Lilly and others to target cancer

Getting drugs aimed at degrading disease-causing proteins to the right target has been an issue. Companies like Firefly Bio think they can get those drugs to ride along with antibodies to knock out cancers.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks